TYRA | Tyra BiosciencesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$21.37
+$0.04 (+0.19%)

Tyra Biosciences (TYRA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.

The 50 SMA has sat below the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is below both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $21.37 vs 50 $22.48 / 200 $29.80
Projection
No cross projected
Test
No active test
Last cross
Death cross 19 Aug 2026 ยท projected 10 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $21.07 vs 50 $28.93 / 200 $18.19
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 12 Jan 2026 ยท projected 30 bars out

4-hour as of 3 Nov 16:00 ET

Price
between the two $21.37 vs 50 $20.38 / 200 $26.05
Projection
No cross projected
Test
No active test
Last cross
Death cross 3 Jun 2026 ยท projected 9 bars out

Cross history

15
crosses on record since 2023
7 golden8 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
19 Aug 2026Death moderatedaily10 bars outNot tested
3 Jun 2026Death4-hour9 bars outNot tested
week of 12 Jan 2026Golden moderateweekly30 bars outNot tested
25 Sep 2025Golden moderatedaily27 bars outNot tested
week of 25 Aug 2025Death steepweekly5 bars out5 bar cross test

About TYRA

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$13.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.